Filter
7919
Filtered Results: 7919
Text search:
Health
and
Human
Rights
Info
Featured
Recommendations
720
New Publications
2046
Language
Document type
No document type
4486
Studies & Reports
1333
Guidelines
936
Manuals
442
Strategic & Response Plan
302
Fact sheets
157
Training Material
139
Situation Updates
65
Infographics
20
Brochures
18
Resource Platforms
13
Online Courses
6
App
1
Videos
1
Countries / Regions
Global
335
India
270
Kenya
232
South Africa
155
Ethiopia
154
Nepal
149
Sierra Leone
146
Nigeria
145
Uganda
140
Western and Central Europe
138
Myanmar / Burma
130
Latin America and the Carribbean
128
Liberia
127
Bangladesh
116
Syria
111
Zambia
110
Malawi
99
Tanzania
98
Africa
98
Ghana
93
Rwanda
88
Ukraine
85
Congo, Democratic Republic of
66
Philippines
65
South Sudan
60
South–East Asia Region
57
Indonesia
51
Namibia
51
Lesotho
50
Venezuela
50
Cambodia
47
Asia
47
Eastern Europe
47
Yemen
43
Zimbabwe
42
West and Central Africa
42
Mozambique
41
East and Southern Africa
38
Guinea
37
Middle East and North Africa
37
Brazil
36
Germany
35
Haiti
34
Colombia
32
Senegal
31
Eastern Europe and Central Asia
30
Botswana
29
Russia
26
Cameroon
25
Pakistan
24
Afghanistan
24
Burkina Faso
23
Central African Republic
23
Eswatini/ Swaziland
21
Lebanon
20
Sudan
20
Western Pacific Region
20
Jordan
17
Thailand
17
Somalia
16
Vietnam
16
Moldova
15
Iraq
14
Laos
14
Tajikistan
14
Albania
13
Mali
12
China
12
Georgia
12
USA
10
Turkey
10
Peru
10
Papua New Guinea
9
Bolivia
9
Sri Lanka
9
Angola
8
Paraguay
8
Palestine
8
Iran
8
Greece
7
Libya
7
Madagascar
7
Chile
7
Poland
7
Côte d’Ivoire / Ivory Coast
6
Argentina
6
North Macedonia
6
Hungary
6
Ecuador
6
Mexico
6
North America
6
Jamaica
6
Guinea-Bissau
5
Niger
5
Egypt
5
Benin
5
Armenia
5
Southern Africa
5
Romania
5
Kyrgyzstan
5
Turkmenistan
5
Portugal
5
Chad
4
Gambia
4
Serbia
4
El Salvador
4
Italy
4
Timor Leste/ East Timor
4
Uzbekistan
4
Kazakhstan
4
United Kingdom
4
Spain
4
Saudi Arabia
3
Malaysia
3
Croatia
3
Burundi
3
Honduras
3
Guatemala
3
Bhutan
3
Canada
3
Japan
3
Belarus
3
Bosnia and Herzegovina
3
Morocco
2
Singapore
2
Nicaragua
2
Fiji
2
Djibouti
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Mauritius
2
Tunisia
2
Azerbaijan
2
Togo
1
Mauritania
1
Ireland
1
Vanuatu
1
Dominican Republic
1
Switzerland
1
Cuba
1
Other region
1
Solomon Islands
1
North Korea
1
Mongolia
1
Qatar
1
Australia
1
Gabon
1
Denmark
1
Belgium
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2721
Clinical Guidelines
554
Women & Child Health
480
Public Health
427
Key Resources
400
Capacity Building
162
Pharmacy & Technologies
77
Annual Report MEDBOX
3
Toolboxes
COVID-19
665
HIV
662
Mental Health
660
Disability
449
TB
348
Planetary Health
319
Conflict
274
Caregiver
220
Rapid Response
212
Refugee
208
AMR
197
Ebola
176
Global Health Education
170
NTDs
164
Pharmacy
126
Natural Hazards
115
NCDs
83
Health Financing Toolbox
67
Social Ethics
51
Specific Hazards
47
Zika
45
Cholera
35
Polio
31
Typhoon
3
South Sudan
2
Health Financing
1
Calls for greater implementation research (IR) capacity came in the wake of compelling evidence that implementation strategies are critically important for the dissemination and facilitation of evidence-in...rmed policies and interventions to tackle noncommunicable diseases (NCDs), thereby improving outcomes for both individuals and populations. However, at present, implementation of evidence-based interventions and policies is challenged by a gap in lack of academic research on how these cost–effective recommended interventions can be implemented in the context of local settings, especially those of low and middle-income.
Health care-associated infection (HCAI) places a serious disease burden and has a significant economic impact on patients and ...-care systems throughout the world. Yet good hand hygiene, the simple task of cleaning hands at the right times and in the right way, can save lives. World Health Organization (WHO) has developed evidence-based WHO Guidelines on Hand Hygiene in Health Care to support health-care facilities to improve hand hygiene and thus reduce HCAI.
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available ...rmation critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the manual is available in a compiled form and in several separate modules that can be consulted individually. For each module, specific training material is also available to facilitate implementation.
Tackling COVID-19 misinformation. Ensuring communities have access to lifesaving public health information from trusted sources and are not misled...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research ...
This manual is designed to orient helpers to offer psychologicalfirst aid (PFA) to people following a serious crisis event. PFA involves humane, supportive and practical assistance for people who ar...
This document provides interim guidance for effective risk communication around Zika virus transmission and potential complications. A causal relationship between Zika virus infection and these pote...
The World Health Organization's Model Disability Survey (MDS) Manual is a tool to help implement the MDS in countries and to improve the quality of the interview process. This manual is intended to ...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. ...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, a... cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the potential to impact overall global development. It is important, therefore, to elevate AMR beyond health as part of a larger development agenda in the context of the Sustainable Development Goals (SDGs). This report provides in-depth technical discussions in areas that have direct implications to the containment of AMR as a development agenda. The report is organized in five chapters which served as the technical background documents for the Biregional Technical Consultation on AMR in Asia, 14-15 April 2016. More information from the meeting is available in the WHO Meeting Report: Biregional Technical Consultation on Antimicrobial Resistance in Asia. The meeting was the first time senior officials from the Ministry of Health and Ministry of Agriculture across Asia came together to tackle AMR
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals ... negatively impacted on healthcare systems’ ability to provide population-wide access to essential medicines.
Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products.
This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and developme...
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles ... timelines for all stakeholders. The GPIRM also summarizes information about innovative new products being developed and sets out the immediate research and development priorities.
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human ... animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite victims; and (v) a proposed process for validation and verification of countries reaching zero human deaths from rabies.
Policy and practice for maturity-aligned engagement of children in decisions about HIV-related medical and social services and management of confid...
As knowledge on Ebola-related safety measures accumulates, this guidance is provisional. This guide focuses on psychological first aid, which involves humane, supportive and practical help to follo...
To improve the quality of care during labour and childbirth, facilitate effective implementation of the World Health Organization (WHO) recommendations: Intrapartum care for a positive childbirth ex...
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring ... evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicine-related adverse effects in humans, promoting patient safety, and the rational use of medicines. The indicators proposed in this manual are based on the expected functions of pharmacovigilance centres as described in the WHO Mimimum Requirements for a Functional Pharmacovigilance System (1) (see Annex 1 of the manual).
